Cargando…

Randomized, multicenter, open-label trial of autologous cytokine-induced killer cell immunotherapy plus chemotherapy for squamous non-small-cell lung cancer: NCT01631357

Detalles Bibliográficos
Autores principales: Liu, Liang, Gao, Quanli, Jiang, Jingting, Zhang, Junping, Song, Xin, Cui, Jiuwei, Ye, Yunbin, Wang, Zhiyu, Zhang, Xinwei, Ren, Xiubao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572396/
https://www.ncbi.nlm.nih.gov/pubmed/33077722
http://dx.doi.org/10.1038/s41392-020-00337-x
_version_ 1783597333872640000
author Liu, Liang
Gao, Quanli
Jiang, Jingting
Zhang, Junping
Song, Xin
Cui, Jiuwei
Ye, Yunbin
Wang, Zhiyu
Zhang, Xinwei
Ren, Xiubao
author_facet Liu, Liang
Gao, Quanli
Jiang, Jingting
Zhang, Junping
Song, Xin
Cui, Jiuwei
Ye, Yunbin
Wang, Zhiyu
Zhang, Xinwei
Ren, Xiubao
author_sort Liu, Liang
collection PubMed
description
format Online
Article
Text
id pubmed-7572396
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-75723962020-10-20 Randomized, multicenter, open-label trial of autologous cytokine-induced killer cell immunotherapy plus chemotherapy for squamous non-small-cell lung cancer: NCT01631357 Liu, Liang Gao, Quanli Jiang, Jingting Zhang, Junping Song, Xin Cui, Jiuwei Ye, Yunbin Wang, Zhiyu Zhang, Xinwei Ren, Xiubao Signal Transduct Target Ther Letter Nature Publishing Group UK 2020-10-19 /pmc/articles/PMC7572396/ /pubmed/33077722 http://dx.doi.org/10.1038/s41392-020-00337-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter
Liu, Liang
Gao, Quanli
Jiang, Jingting
Zhang, Junping
Song, Xin
Cui, Jiuwei
Ye, Yunbin
Wang, Zhiyu
Zhang, Xinwei
Ren, Xiubao
Randomized, multicenter, open-label trial of autologous cytokine-induced killer cell immunotherapy plus chemotherapy for squamous non-small-cell lung cancer: NCT01631357
title Randomized, multicenter, open-label trial of autologous cytokine-induced killer cell immunotherapy plus chemotherapy for squamous non-small-cell lung cancer: NCT01631357
title_full Randomized, multicenter, open-label trial of autologous cytokine-induced killer cell immunotherapy plus chemotherapy for squamous non-small-cell lung cancer: NCT01631357
title_fullStr Randomized, multicenter, open-label trial of autologous cytokine-induced killer cell immunotherapy plus chemotherapy for squamous non-small-cell lung cancer: NCT01631357
title_full_unstemmed Randomized, multicenter, open-label trial of autologous cytokine-induced killer cell immunotherapy plus chemotherapy for squamous non-small-cell lung cancer: NCT01631357
title_short Randomized, multicenter, open-label trial of autologous cytokine-induced killer cell immunotherapy plus chemotherapy for squamous non-small-cell lung cancer: NCT01631357
title_sort randomized, multicenter, open-label trial of autologous cytokine-induced killer cell immunotherapy plus chemotherapy for squamous non-small-cell lung cancer: nct01631357
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572396/
https://www.ncbi.nlm.nih.gov/pubmed/33077722
http://dx.doi.org/10.1038/s41392-020-00337-x
work_keys_str_mv AT liuliang randomizedmulticenteropenlabeltrialofautologouscytokineinducedkillercellimmunotherapypluschemotherapyforsquamousnonsmallcelllungcancernct01631357
AT gaoquanli randomizedmulticenteropenlabeltrialofautologouscytokineinducedkillercellimmunotherapypluschemotherapyforsquamousnonsmallcelllungcancernct01631357
AT jiangjingting randomizedmulticenteropenlabeltrialofautologouscytokineinducedkillercellimmunotherapypluschemotherapyforsquamousnonsmallcelllungcancernct01631357
AT zhangjunping randomizedmulticenteropenlabeltrialofautologouscytokineinducedkillercellimmunotherapypluschemotherapyforsquamousnonsmallcelllungcancernct01631357
AT songxin randomizedmulticenteropenlabeltrialofautologouscytokineinducedkillercellimmunotherapypluschemotherapyforsquamousnonsmallcelllungcancernct01631357
AT cuijiuwei randomizedmulticenteropenlabeltrialofautologouscytokineinducedkillercellimmunotherapypluschemotherapyforsquamousnonsmallcelllungcancernct01631357
AT yeyunbin randomizedmulticenteropenlabeltrialofautologouscytokineinducedkillercellimmunotherapypluschemotherapyforsquamousnonsmallcelllungcancernct01631357
AT wangzhiyu randomizedmulticenteropenlabeltrialofautologouscytokineinducedkillercellimmunotherapypluschemotherapyforsquamousnonsmallcelllungcancernct01631357
AT zhangxinwei randomizedmulticenteropenlabeltrialofautologouscytokineinducedkillercellimmunotherapypluschemotherapyforsquamousnonsmallcelllungcancernct01631357
AT renxiubao randomizedmulticenteropenlabeltrialofautologouscytokineinducedkillercellimmunotherapypluschemotherapyforsquamousnonsmallcelllungcancernct01631357